The global penicillin market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the high prevalence of infectious diseases such as lower respiratory infections, malaria, tuberculosis, among others. In 2020, Africa had the highest prevalence of tuberculosis incidence per 100, 000 population. The incidence rate was about 220. Similarly, Americas reported some 29 new cases of tuberculosis per 100,000 inhabitants. Additionally, growing initiatives and investments by government organizations and pharmaceutical & biotechnology companies across the globe for developing novel antibiotics have significantly increased the demand for penicillin worldwide. Additionally, the growing adoption of new drugs in the healthcare sector has significantly increased, thereby supporting the growth of global penicillin market. Besides, increasing awareness about novel treatments will further increase the demand for penicillin in the coming years, thereby supporting the market growth.

Growing Prevalence of Various Types of Infections

Every day the frequency of bacterial infections is increasing. The main reason for increasing bacterial infection is not maintaining proper health, not washing hands before eating or cooking, sneezing without covering, and poor sanitation and hygiene practices. This has significantly increased the demand for antibiotics, thereby creating lucrative growth opportunities for the penicillin market during the forecast period. In 2021, the daily defined dose of antibiotics consumption in Italy was around 13 per 1,000 inhabitants. Similarly, in low and middle-income countries public transport is the main source of communication and most of the spread of bacterial infections is being witnessed due to use of public transports, thereby increasing the demand for antibiotics and creating opportunities for the growth of penicillin market.

 

Expanding Research & Development Activities

Growing incidence of antibiotic resistance in bacteria and increasing prevalence of various communicable bacterial infections has made biotechnology and pharmaceutical companies focus on developing new and advanced therapies and products. This in turn is expected to create new prospects for the growth of penicillin market. According to clinicaltrials.gov, there are around 93 clinical trials related to penicillin which are under different phases. Similarly, betterment in the new drug approval process is expected to boost market growth over the years. In 2020, Merck received an acceptance for a review of a supplemental new drug application from the U.S FDA for RECARBRIO intended for HABP/VABP. The growing burden of infectious diseases is compelling government and non-government organizations for investing in research and development activities that will further boost the development of novel antibiotics and create new policies for the development of new drugs.

 


Download Free Sample Report


Market Segmentation

The global penicillin market can be segmented by product, type, route of administration, end-user, and by region. Based on the product, the market can be divided into Bulk and Dosage. Based on type, the market can be segmented into Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, and Others. Based on the route of administration, the market can be differentiated into Oral, Intramuscular, and Intravenous. Based on end users, the market can be grouped into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global penicillin market on account of the increasing prevalence of infectious in the country. According to Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases is around 7.2 million.

 

Recent Development

In August 2022, PAION AG launched XERAVA (eravacycline), in Germany, for the treatment of complicated intra-abdominal infections (cIAI) in adults.


In October 2021, the Cephalosporin antibiotics branch of GSK was purchased by Novartis. It is currently the exclusive owner of three well-known brands in more than 100 markets, establishing its position as the top manufacturer of antibiotics across the globe.

 

Market Players

Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc. are some of the leading players operating in the Global Penicillin Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         By Product

·         By Type

·         By Route of Administration

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global penicillin market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

         Penicillin Market, By Product:

o      Bulk

o      Dosage

·         Penicillin Market, By Type:

o      Aminopenicillin

o      Antipseudomonal Penicillin

o      Beta Lactamase Inhibitor

o      Others

·        


Penicillin Market, By Route of Administration:

o      Oral

o      Intramuscular

o      Intravenous

·        

     Penicillin Market, By Route of End User:

o      Hospitals & Clinics

o      Pharmaceutical & Biotechnology Companies

o      Academic & Research Institutions

·        


Penicillin Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Penicillin Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Clinical Trial Analysis

5.1.  Ongoing Clinical Trials

5.2.  Completed Clinical Trials

5.3.  Terminated Clinical Trials

5.4.  Breakdown of Pipeline, By Development Phase

5.5.  Breakdown of Pipeline, By Status

5.6.  Breakdown of Pipeline, By Study Type

5.7.  Breakdown of Pipeline, By Region

5.8.  Clinical Trials Heat Map

6.    Global Penicillin Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Product (Bulk, Dosage)

6.2.2.     By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)

6.2.3.     By Route of Administration (Oral, Intramuscular, Intravenous)

6.2.4.     By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)

6.2.5.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

6.2.6.     By Company (2022)

6.3.  Market Map

6.3.1.     By Product

6.3.2.     By Application

6.3.3.     By Technique

6.3.4.     By Source

6.3.5.     By Region

7.    North America Penicillin Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Type

7.2.3.     By Route of Administration

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Penicillin Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value & Volume

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Type

7.3.1.2.3.             By Route of Administration

7.3.1.2.4.             By End User

7.3.2.     Canada Penicillin Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value & Volume

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Type

7.3.2.2.3.             By Route of Administration

7.3.2.2.4.             By End User

7.3.3.     Mexico Penicillin Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Type

7.3.3.2.3.             By Route of Administration

7.3.3.2.4.             By End User

8.    Europe Penicillin Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Type

8.2.3.     By Route of Administration

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Penicillin Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value & Volume

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Type

8.3.1.2.3.             By Route of Administration

8.3.1.2.4.             By End User

8.3.2.     Germany Penicillin Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value & Volume

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Type

8.3.2.2.3.             By Route of Administration

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Penicillin Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value & Volume

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Type

8.3.3.2.3.             By Route of Administration

8.3.3.2.4.             By End User

8.3.4.     Italy Penicillin Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value & Volume

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Type

8.3.4.2.3.             By Route of Administration

8.3.4.2.4.             By End User

8.3.5.     Spain Penicillin Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value & Volume

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Type

8.3.5.2.3.             By Route of Administration

8.3.5.2.4.             By End User

9.    Asia-Pacific Penicillin Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Type

9.2.3.     By Route of Administration

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Penicillin Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value & Volume

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Type

9.3.1.2.3.             By Route of Administration

9.3.1.2.4.             By End User

9.3.2.     India Penicillin Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value & Volume

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Type

9.3.2.2.3.             By Route of Administration

9.3.2.2.4.             By End User

9.3.3.     Japan Penicillin Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value & Volume

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Type

9.3.3.2.3.             By Route of Administration

9.3.3.2.4.             By End User

9.3.4.     South Korea Penicillin Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value & Volume

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Type

9.3.4.2.3.             By Route of Administration

9.3.4.2.4.             By End User

9.3.5.     Australia Penicillin Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value & Volume

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Type

9.3.5.2.3.             By Route of Administration

9.3.5.2.4.             By End User

10.  South America Penicillin Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Type

10.2.3.  By Route of Administration

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Penicillin Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value & Volume

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Type

10.3.1.2.3.           By Route of Administration

10.3.1.2.4.           By End User

10.3.2.  Argentina Penicillin Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value & Volume

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Type

10.3.2.2.3.           By Route of Administration

10.3.2.2.4.           By End User

10.3.3.  Colombia Penicillin Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value & Volume

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Type

10.3.3.2.3.           By Route of Administration

10.3.3.2.4.           By End User

11.  Middle East and Africa Penicillin Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Type

11.2.3.  By Route of Administration

11.2.4.  By End User

11.2.5.